Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by chplanque
Group name EquipeADV
Item Type Journal Article
Title An Alternative Role of RluD in the Fidelity of Translation Initiation in Escherichia coli
Creator Lahry et al.
Author Kuldeep Lahry
Author Aiswarya Gopal
Author Amit Kumar Sahu
Author Carmelita Nora Marbaniang
Author Riyaz Ahmad Shah
Author Avani Mehta
Author Umesh Varshney
Abstract

J Mol Biol. 2022 Jun 30;434(12):167588. doi: 10.1016/j.jmb.2022.167588. Epub 2022 Apr 16.

ABSTRACT

The fidelity of initiator tRNA (i-tRNA) selection in the ribosomal P-site is a key step in translation initiation. The highly conserved three consecutive G:C base pairs (3GC pairs) in the i-tRNA anticodon stem play a crucial role in its selective binding in the P-site. Mutations in the 3GC pairs (3GC mutant) render the i-tRNA inactive in initiation. Here, we show that a mutation (E265K) in the unique C-terminal tail domain of RluD, a large ribosomal subunit pseudouridine synthase, results in compromised fidelity of initiation and allows initiation with the 3GC mutant i-tRNA. RluD modifies the uridine residues in H69 to pseudouridines. However, the role of its C-terminal tail domain remained unknown. The E265K mutation does not diminish the pseudouridine synthase activity of RluD, or the growth phenotype of Escherichia coli, or cause any detectable defects in the ribosomal assembly in our assays. However, in our in vivo analyses, we observed that the E265K mutation resulted in increased retention of the ribosome binding factor A (RbfA) on 30S suggesting a new role of RluD in contributing to RbfA release, a function which may be attributed to its (RluD) C-terminal tail domain. The studies also reveal that deficiency of RbfA release from 30S compromises the fidelity of i-tRNA selection in the ribosomal P-site.

PMID:35439479 | DOI:10.1016/j.jmb.2022.167588

Publication Journal of molecular biology
Date 2022-04-19 00:00:00
Language en
DOI 10.1016/j.jmb.2022.167588
URL https://pubmed.ncbi.nlm.nih.gov/35439479/?utm_source=Firefox&utm_medium=rss&utm_campaign=pubmed-2&utm_content=16WqI68KDOBEDOCNE1P3RxYQYPTwTutpbvUaDhoUuYPuJd459j&fc=20250120064306&ff=20250120064533&v=2.18.0.post9+e462414
Tags first, original
Date Added 2025/01/20 - 14:26:34
Date Modified 2025/01/20 - 14:54:46
Notes and Attachments (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés